InflaRx and cur­rent share­hold­ers placed $ 117,3 Mio. of shares, with $ 63 Mio. as pri­mary shares with the pro­ceeds going to InflaRx and $

The Stiftung für Tech­nolo­gie, Inno­va­tion und Forschung Thürin­gen (STIFT) and the Sparkasse Jena-Saale-Hol­z­­land invest in an inno­v­a­tive ther­a­peu­tics com­pany in Jena Smart­Dye­Liv­ery, in Jena, uses nanoparticles

World­wide, tuber­cu­lo­sis claims about 1.5 mil­lion vic­tims per year. It is one of the most dan­ger­ous dis­eases caused by bac­te­ria. The increas­ing spread of multi-resistant

The mag­a­zine brand eins hon­ours oncg­nos­tics GmbH from Jena as one of the most inno­v­a­tive com­pa­nies in Ger­many in the indus­try “Chem­istry, Pharma & Biotechnology”.

BianoGMP GmbH receives invest­ment cap­i­tal from the Thuringia Start-up Fund (TSF) for the pro­duc­tion of DNA- and RNA-based active agents. There is still a lack

The bm|t is pleased to announce that seven of its Investee Part­ners have already closed fund­ing rounds in 2018. Over €10 mil­lion has been raised

Jena-based siOP­TICA GmbH has closed a €4M growth financ­ing deal with bm|t and Capital‑E II ARKIV (Capital‑E), Antwerp. With the fresh cap­i­tal, siOP­TICA will extend

Kevin Reeder (Man­ag­ing Direc­tor of bm|t) will give a pre­sen­ta­tion at the ThEEN (Thüringer Erneuer­bare Energien Net­zw­erk e.V.) spe­cial­ist forum on 16.04.2018 in Erfurt. The expert

In the 2017 finan­cial year, over EUR 150 mil­lion flowed from pri­vate domes­tic and for­eign investors from the net­work of bm‑t beteili­gungs­man­age­ment thürin­gen gmbh (bm|t),

On 19 and 20 June 2018, entre­pre­neurs and investors will meet for the 15^th time at the Investor Days Thuringia at Messe Erfurt. Under the

It’s been just under a year since the founders of ifesca raised the seed round for their start-up. At that time, a high six-fig­ure sum

oncg­nos­tics GmbH has already reached the fund­ing limit of € 750,000 on the crowd­fund­ing plat­form seed­match 39 days before the end of the cam­paign. The first